By ThinkSabio Admin #Thinksabio, SEC-Update: #NTRB: $6.23
Sector: Healthcare
YTD: 169.70 %
SEC reported Today (19-SEP-2024) that T.I.I. – JETSERVICES, LDA has INCREASED #NTRB shares
Before: 1,347,524 Shares
Now: 4,179,842 Shares
Status: INCREASED by 210.00%
Ownership: 32.37%
Approx Invested Value: $14.16M
Read Report: https://www.thinksabio.com/reports/isr/NTRB
Nutriband Inc. (NTRB)
Referred from YAHOO finance
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company’s lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.